Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03104491
Title Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia and Non-Hodgkin's Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Leland Metheny
Indications

diffuse large B-cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

B-cell lymphoma

acute lymphoblastic leukemia

non-Hodgkin lymphoma

Therapies

Inotuzumab ozogamicin

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.